Increased risk of mortality by fibrosis stage in nonalcoholic fatty liver disease: Systematic review and meta-analysis-Reference-Cited by-同舟云学术

Increased risk of mortality by fibrosis stage in nonalcoholic fatty liver disease: Systematic review and meta-analysis

Published:2017-03-31 Issue:5 Volume:65 Page:1557-1565
ISSN:0270-9139
Container-title:Hepatology
language:en
Short-container-title:Hepatology

Author:

Dulai Parambir S.¹²,Singh Siddharth¹²,Patel Janki¹,Soni Meera¹,Prokop Larry J.³,Younossi Zobair⁴,Sebastiani Giada⁵,Ekstedt Mattias⁶,Hagstrom Hannes⁷,Nasr Patrik⁶,Stal Per⁷,Wong Vincent Wai-Sun⁸,Kechagias Stergios⁶,Hultcrantz Rolf⁷,Loomba Rohit¹²

Affiliation:

1. NAFLD Research Center; University of California at San Diego; La Jolla CA

2. Division of Gastroenterology and Hepatology; University of California at San Diego; La Jolla CA

3. Department of Library Services; Mayo Clinic; Rochester MN

4. Center for Liver Disease, Department of Medicine; Inova Fairfax Hospital; Falls Church VA

5. Department of Medicine; McGill University Health Centre; Montreal Quebec Canada

6. Department of Medical and Health Sciences; Linkoping University; Linkoping Sweden

7. Department of Gastroenterology and Hepatology; Karolinska University Hospital, Karolinska Institutet; Stockholm Sweden

8. Department of Medicine and Therapeutics; Chinese University of Hong Kong; Hong Kong

Funder

American Gastroenterological Association Foundation-Sucampo-ASP Designated Research Award in Geriatric Gastroenterology

T. Franklin Williams Scholarship Award

National Institute of Diabetes and Digestive and Kidney Diseases

National Institute of Environmental Health Sciences

Fonds de Recherche du Québec - Santé

Publisher

Wiley

Subject

Hepatology

Reference23 articles.

1. Nonalcoholic fatty liver disease: a systematic review;Rinella;JAMA,2015

2. Global epidemiology of nonalcoholic fatty liver disease-meta-analytic assessment of prevalence, incidence, and outcomes;Younossi;Hepatology,2016

3. Nonalcoholic fatty liver disease: a spectrum of clinical and pathological severity;Matteoni;Gastroenterology,1999

4. The natural history of nonalcoholic fatty liver disease: a population-based cohort study;Adams;Gastroenterology,2005

5. Fibrosis progression in nonalcoholic fatty liver vs nonalcoholic steatohepatitis: a systematic review and meta-analysis of paired-biopsy studies;Singh;Clin Gastroenterol Hepatol,2015

Cited by 1407 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Treatment with 1.25% cholesterol enriched diet produces severe fatty liver disease characterized by advanced fibrosis and inflammation and impaired autophagy in mice;The Journal of Nutritional Biochemistry;2024-12

2. Steatotic liver disease in the context of hematological malignancies and anti-neoplastic chemotherapy;Metabolism;2024-11

3. Diabetes as a risk factor for MASH progression;Diabetes Research and Clinical Practice;2024-11

4. Natural history and progression of metabolic dysfunction-associated steatotic liver disease;The Lancet Gastroenterology & Hepatology;2024-10

5. The relationship between diabetes mellitus and non-alcoholic fatty liver disease: a clinical and instrumental paired study;Terapevticheskii arkhiv;2024-09-14